Open house Arzneimittelrabattverträge zum Wirkstoff Dapagliflozin, ATC A10BK01

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund offers rebate contracts for the aforementioned active ingredient to all interested pharmaceutical companies without a selection decision. The contracts are concluded under an "Open House model." The offered contracts are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. The Open House model applies uniform conditions for all participants. Contract contents, conditions, and access procedures are uniform – individual negotiations are not conducted. The contract terms are a maximum of 24 months, with the earliest contract start date being 01.09.2026. All contracts end at the latest 24 months after the earliest contract start date, regardless of the date of the respective contract conclusion. Joining or concluding a contract can occur within the 24-month period on the first day of any month. There is a termination right with 6 weeks' notice to the end of the month in accordance with the provisions of the contract. Further information on termination possibilities is included in the contract documents. AOK…

TENDER BRIEF

TENDER DOCUMENTS